Literature DB >> 15972636

The influence of effector T cells and Fas ligand on lupus-associated B cells.

Michele L Fields1, Simone A Nish, Brian D Hondowicz, Michele H Metzgar, Gina N Wharton, Andrew J Caton, Jan Erikson.   

Abstract

Circulating autoantibodies against dsDNA and chromatin are a characteristic of systemic lupus erythematosus in humans and many mouse models of this disease. B cells expressing these autoantibodies are normally regulated in nonautoimmune-prone mice but are induced to secrete Abs following T cell help. Likewise, anti-chromatin autoantibody production is T cell-dependent in Fas/Fas ligand (FasL)-deficient (lpr/lpr or gld/gld) mice. In this study, we demonstrate that Th2 cells promote anti-chromatin B cell survival and autoantibody production in vivo. FasL influences the ability of Th2 cells to help B cells, as Th2-gld/gld cells support higher titers of anti-chromatin Abs than their FasL-sufficient counterparts and promote anti-chromatin B cell participation in germinal centers. Th1 cells induce anti-chromatin B cell germinal centers regardless of FasL status; however, their ability to stimulate anti-chromatin Ab production positively correlates with their level of IFN-gamma production. This distinction is lost if FasL-deficient T cells are used: Th1-gld/gld cells promote significant titers of anti-chromatin Abs regardless of IFN-gamma production levels. Thus, FasL from effector T cells plays an important role in determining the fate of anti-chromatin B cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972636     DOI: 10.4049/jimmunol.175.1.104

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Autoantibody production in lpr/lpr gld/gld mice reflects accumulation of CD4+ effector cells that are resistant to regulatory T cell activity.

Authors:  Brian D Hondowicz; Michele L Fields; Simone A Nish; Joseph Larkin; Andrew J Caton; Jan Erikson
Journal:  J Autoimmun       Date:  2008-06-09       Impact factor: 7.094

2.  T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells.

Authors:  Robin A Herlands; Sean R Christensen; Rebecca A Sweet; Uri Hershberg; Mark J Shlomchik
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

3.  ICOS expression by effector T cells influences the ability of regulatory T cells to inhibit anti-chromatin B cell responses in recipient mice.

Authors:  Brian D Hondowicz; Amrita O Batheja; Michele H Metzgar; Andrew J Caton; Jan Erikson
Journal:  J Autoimmun       Date:  2009-12-22       Impact factor: 7.094

4.  Efficient help for autoreactive B-cell activation requires CD4+ T-cell recognition of an agonist peptide at the effector stage.

Authors:  Brian D Hondowicz; Amrita O Batheja; Michele H Metzgar; Antonio J Pagán; Olivia A Perng; Simone Willms; Andrew J Caton; Jan Erikson
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

5.  Fas expression on antigen-specific T cells has costimulatory, helper, and down-regulatory functions in vivo for cytotoxic T cell responses but not for T cell-dependent B cell responses.

Authors:  Irina Puliaeva; Roman Puliaev; Andrei Shustov; Mark Haas; Charles S Via
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

6.  Influence of interleukin-2 deficiency on the generation of autoimmune B cells.

Authors:  Lucile E Wrenshall; Deandra R Smith; Elliot T Stevens; John D Miller
Journal:  J Autoimmun       Date:  2007-08-09       Impact factor: 7.094

7.  Role of B cells in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Laura Mandik-Nayak; Natalie Ridge; Michele Fields; Audrey Y Park; Jan Erikson
Journal:  Curr Opin Immunol       Date:  2008-09-18       Impact factor: 7.486

8.  Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction.

Authors:  Anthony C Cruz; Madhu Ramaswamy; Claudia Ouyang; Christopher A Klebanoff; Prabuddha Sengupta; Tori N Yamamoto; Françoise Meylan; Stacy K Thomas; Nathan Richoz; Robert Eil; Susan Price; Rafael Casellas; V Koneti Rao; Jennifer Lippincott-Schwartz; Nicholas P Restifo; Richard M Siegel
Journal:  Nat Commun       Date:  2016-12-23       Impact factor: 14.919

Review 9.  Linking CD1-Restricted T Cells With Autoimmunity and Dyslipidemia: Lipid Levels Matter.

Authors:  Sreya Bagchi; Samantha Genardi; Chyung-Ru Wang
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.